CompareMarketResearchRequest a sample
Home / Healthcare / Cell Culture

Healthcare · Market report

Cell Culture Market Size, Share and Forecast 2026-2036

The global cell culture market is worth USD 23.9 bn in 2026 and is forecast to reach USD 51.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Vessels and consumables is the largest by product segment.

USD 23.9 bnMarket size 2026
USD 51.5 bnForecast 2036
8.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global cell culture market is worth USD 23.9 bn in 2026 and is forecast to reach USD 51.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Vessels and consumables is the largest by product segment.

ScopeConsumables for growing cells in the laboratory and in biomanufacturing: media, sera, supplements, reagents, flasks, plates and bags, excluding instruments.
IndustryHealthcare
Value 2025USD 22.0 bn
Value 2026USD 23.9 bn
Value 2036USD 51.5 bn
CAGR 2026-20368.0%
Volume 20263,760 million units
Volume 20367,349 million units
Average price 2026USD 6.35 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Cell Culture market size and forecast, 2026-2036

Exhibit 1The global cell culture market is forecast to grow from USD 23.9 bn in 2026 to USD 51.5 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 8.0%
Cell Culture market value, 2025 to 2036Market value by year. 2025: USD 22.0 bn; 2026: USD 23.9 bn; 2027: USD 25.8 bn; 2028: USD 27.8 bn; 2029: USD 30.1 bn; 2030: USD 32.5 bn; 2031: USD 35.1 bn; 2032: USD 37.9 bn; 2033: USD 40.9 bn; 2034: USD 44.2 bn; 2035: USD 47.7 bn; 2036: USD 51.5 bn. Compound annual growth rate 2026 to 2036: 8.0%.202523.9 bn202635.1 bn203151.5 bn20368.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 23.9 bn
2027USD 25.8 bn
2028USD 27.8 bn
2029USD 30.1 bn
2030USD 32.5 bn
2031USD 35.1 bn
2032USD 37.9 bn
2033USD 40.9 bn
2034USD 44.2 bn
2035USD 47.7 bn
2036USD 51.5 bn

Cell Culture market segmentation

By product

Exhibit 2Vessels and consumables is the largest segment by product, with 34.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Cell Culture market share by product, 2026Share of 2026 revenue by product. Vessels and consumables: 34.0%; Media and supplements: 32.0%; Reagents: 22.0%; Sera: 12.0%.Vessels and consumables34.0%Media and supplements32.0%Reagents22.0%Sera12.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Media and supplements32.0%32.3%USD 7.6 bn8.1%
Sera12.0%9.6%USD 2.9 bn5.6%
Reagents22.0%22.2%USD 5.3 bn8.1%
Vessels and consumables34.0%35.9%USD 8.1 bn8.6%

By end use

Exhibit 3Biopharma bioprocessing adds the most revenue by end use, growing from USD 11.5 bn in 2026 to USD 26.3 bn by 2036Estimated revenue in USD by end use, 2026 and 2036 forecast
Cell Culture market by end use, 2026 and 2036Revenue by end use in 2026 and 2036. Biopharma bioprocessing: USD 11.5 bn in 2026, USD 26.3 bn in 2036, change +130%; Cell and gene therapy: USD 3.3 bn in 2026, USD 11.0 bn in 2036, change +228%; Academic and research: USD 5.7 bn in 2026, USD 8.7 bn in 2036, change +51%; Diagnostics and vaccines: USD 3.3 bn in 2026, USD 5.6 bn in 2036, change +66%.20262036 forecastChangeBiopharma bioprocessing+130%11.5 bn26.3 bnCell and gene therapy+228%3.3 bn11.0 bnAcademic and research+51%5.7 bn8.7 bnDiagnostics and vaccines+66%3.3 bn5.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biopharma bioprocessing48.0%51.1%USD 11.5 bn8.7%
Academic and research24.0%16.8%USD 5.7 bn4.2%
Cell and gene therapy14.0%21.3%USD 3.3 bn12.6%
Diagnostics and vaccines14.0%10.8%USD 3.3 bn5.2%

By consumables type

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Sera20.0%16.0%USD 4.8 bn5.6%
Media30.0%30.0%USD 7.2 bn8.0%
Reagents and supplements24.0%24.0%USD 5.7 bn8.0%
Vessels and plates26.0%30.0%USD 6.2 bn9.6%

By cell source

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Mammalian70.0%68.0%USD 16.7 bn7.7%
Insect8.0%9.0%USD 1.9 bn9.3%
Microbial12.0%12.0%USD 2.9 bn8.0%
Stem and primary cells10.0%11.0%USD 2.4 bn9.0%

By format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Adherent culture40.0%34.0%USD 9.5 bn6.3%
Suspension culture48.0%52.0%USD 11.5 bn8.9%
3D and organoid culture12.0%14.0%USD 2.9 bn9.7%

Top 25 countries for cell culture by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.5% of 2026 revenue and the 25 countries below together hold 96.1%.

Exhibit 4United States is the largest country market at USD 9.1 bn in 2026, and the three largest countries hold 58.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Cell Culture market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 9.1 bn, 38.0%; China: USD 2.9 bn, 12.0%; Germany: USD 1.9 bn, 8.0%; United Kingdom: USD 1.2 bn, 5.0%; Japan: USD 1.2 bn, 5.0%; Switzerland: USD 955 mn, 4.0%; France: USD 955 mn, 4.0%; South Korea: USD 955 mn, 4.0%; India: USD 835 mn, 3.5%; Singapore: USD 716 mn, 3.0%.United States9.1 bn 38.0%China2.9 bn 12.0%Germany1.9 bn 8.0%United Kingdom1.2 bn 5.0%Japan1.2 bn 5.0%Switzerland955 mn 4.0%France955 mn 4.0%South Korea955 mn 4.0%India835 mn 3.5%Singapore716 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 9.1 bn38.0%USD 18.3 bn7.3%
2ChinaUSD 2.9 bn12.0%USD 8.0 bn10.8%
3GermanyUSD 1.9 bn8.0%USD 3.7 bn6.7%
4United KingdomUSD 1.2 bn5.0%USD 2.3 bn6.9%
5JapanUSD 1.2 bn5.0%USD 2.1 bn5.9%
6SwitzerlandUSD 955 mn4.0%USD 1.9 bn7.2%
7FranceUSD 955 mn4.0%USD 1.9 bn6.9%
8South KoreaUSD 955 mn4.0%USD 2.4 bn9.8%
9IndiaUSD 835 mn3.5%USD 2.5 bn11.7%
10SingaporeUSD 716 mn3.0%USD 1.6 bn8.7%
11NetherlandsUSD 391 mn1.6%USD 825 mn7.7%
12DenmarkUSD 353 mn1.5%USD 747 mn7.8%
13ItalyUSD 296 mn1.2%USD 629 mn7.8%
14SpainUSD 215 mn0.9%USD 454 mn7.8%
15AustraliaUSD 193 mn0.8%USD 412 mn7.9%
16CanadaUSD 150 mn0.6%USD 320 mn7.8%
17BelgiumUSD 136 mn0.6%USD 289 mn7.8%
18IsraelUSD 124 mn0.5%USD 263 mn7.8%
19BrazilUSD 105 mn0.4%USD 247 mn8.9%
20TaiwanUSD 88 mn0.4%USD 206 mn8.8%
21IrelandUSD 62 mn0.3%USD 134 mn8.0%
22SwedenUSD 48 mn0.2%USD 103 mn8.0%
23AustriaUSD 48 mn0.2%USD 103 mn8.0%
24RussiaUSD 43 mn0.2%USD 103 mn9.1%
25PolandUSD 31 mn0.1%USD 72 mn8.8%
Rest of worldUSD 938 mn3.9%USD 1.9 bn7.3%
Exhibit 5United States and China account for 52% of the USD 27.7 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Cell Culture market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 23.9 bn. United States: +USD 9.2 bn; China: +USD 5.1 bn; Germany: +USD 1.7 bn; India: +USD 1.7 bn; South Korea: +USD 1.5 bn; 20 other countries: +USD 7.5 bn; Rest of world: +USD 958 mn. Market value 2036: USD 51.5 bn.Market value 202623.9 bnUnited States+9.2 bnChina+5.1 bnGermany+1.7 bnIndia+1.7 bnSouth Korea+1.5 bn20 other countries+7.5 bnRest of world+958 mnMarket value 203651.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Corning
  • Sartorius
  • Cytiva

Group 2: Regional and specialist players

  • Lonza
  • FUJIFILM Irvine Scientific
  • Eppendorf
  • Avantor
  • Becton Dickinson
  • Greiner Bio-One
  • Miltenyi Biotec
  • Takara Bio
  • STEMCELL Technologies

Group 3: Emerging and niche players

  • HiMedia Laboratories
  • PromoCell
  • Bio-Techne
  • PAN-Biotech
  • Capricorn Scientific
  • Wuhan Procell

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the cell culture market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.

The market is divided by product, by end use, by consumables type, by cell source, by format. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the cell culture market?

The global cell culture market is estimated at USD 22.0 bn in 2025 and USD 23.9 bn in 2026.

How fast will the cell culture market grow?

It is forecast to reach USD 51.5 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 27.7 bn.

Which country is the largest market for cell culture?

United States is the largest market by revenue at USD 9.1 bn in 2026, 38.0% of the global total. The three largest countries together hold 58.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 11.7% a year from 2026 to 2036.

Which cell culture segment is largest?

In the by product split, Vessels and consumables is the largest segment with 34.0% of 2026 revenue.

Who are the leading cell culture companies?

Global leaders include Thermo Fisher Scientific, Merck KGaA, Danaher, Corning.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Catheter-Directed Thrombolysis Cell Culture Media →

All Healthcare markets →

Request a sample